CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 26.95 Min. order: 1 piece ★★★★★ 4.0 (174 reviews) Sold : Login>>
Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had ≥1 weight-related complication, individuals assigned to a combination US$ 21.26 Min. order: 1 piece ★★★★★ 4.1 (96 reviews) Sold : Login>>
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 20.96 Min. order: 1 piece ★★★★★ 4.3 (196 reviews) Sold : Login>>
Cagrilintide: The Next-Gen Peptide for Weight Loss and Satiety US$ 27.52 Min. order: 1 piece ★★★★★ 4.3 (33 reviews) Sold : Login>>
Cagrilintide, Tirzepatide, and Retatrutide Peptides: Comparing Metabolic Mechanisms US$ 23.99 Min. order: 1 piece ★★★★★ 4.9 (78 reviews) Sold : Login>>
Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes US$ 25.63 Min. order: 1 piece ★★★★★ 4.1 (107 reviews) Sold : Login>>